Treatment with anti-cancer agents results in profound changes in lncRNA expression in colon cancer cells


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Using real-time RT-PCR in combination with bioinformatics, we have shown for the first time that the treatment of HCT-116 and HT-29 colon cancer cells with two anti-cancer agents (doxycycline or 3,3′-diindolylmethane) results in profound changes in the intracellular content of several lncRNAs (by up to 100 times). Since many of these RNAs are secreted by tumors into the bloodstream, the obtained results provide a basis for developing more sensitive protocols for serological monitoring of tumor relapse and metastasis, as well as for search of new anti-cancer drugs.

作者简介

O. Zinovieva

Engelhardt Institute of Molecular Biology

Email: niklisitsyn@gmail.com
俄罗斯联邦, Moscow, 119991

E. Grineva

Engelhardt Institute of Molecular Biology

Email: niklisitsyn@gmail.com
俄罗斯联邦, Moscow, 119991

M. Prokofjeva

Engelhardt Institute of Molecular Biology

Email: niklisitsyn@gmail.com
俄罗斯联邦, Moscow, 119991

D. Karpov

Engelhardt Institute of Molecular Biology

Email: niklisitsyn@gmail.com
俄罗斯联邦, Moscow, 119991

G. Krasnov

Engelhardt Institute of Molecular Biology

Email: niklisitsyn@gmail.com
俄罗斯联邦, Moscow, 119991

V. Prassolov

Engelhardt Institute of Molecular Biology

Email: niklisitsyn@gmail.com
俄罗斯联邦, Moscow, 119991

T. Mashkova

Engelhardt Institute of Molecular Biology

Email: niklisitsyn@gmail.com
俄罗斯联邦, Moscow, 119991

N. Lisitsyn

Engelhardt Institute of Molecular Biology

编辑信件的主要联系方式.
Email: niklisitsyn@gmail.com
俄罗斯联邦, Moscow, 119991

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2017